NCT05123105 is a NA clinical trial of 1) cupping therapy in Trigger Point Pain, Myofascial, sponsored by Józef Piłsudski University of Physical Education.

Who is sponsoring NCT05123105?

NCT05123105 is sponsored by Józef Piłsudski University of Physical Education.

What drugs are being tested in NCT05123105?

Interventions in NCT05123105: 1) cupping therapy, 2) control test (no intervention), 3) ischemic compression.

What condition does NCT05123105 study?

NCT05123105 studies Trigger Point Pain, Myofascial.

Is NCT05123105 still recruiting?

NCT05123105 is currently completed. Last updated 17 November 2021.

Last reviewed 2021-11-17 · How we verify

NCT05123105

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Dry Cupping and Ischemic Compression on the Trigger Point on the Upper Trapezius Muscle

Completed NA Last updated 17 November 2021

What this trial tests

NA trial testing 1) cupping therapy in Trigger Point Pain, Myofascial in 25 participants. Completed in 30 March 2021.

Timeline

23 January 2021

Primary endpoint
30 March 2021

30 March 2021

Quick facts

Lead sponsor	Józef Piłsudski University of Physical Education
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	25
Start date	23 January 2021
Primary completion	30 March 2021
Estimated completion	30 March 2021
Sites	1 location across Poland

Drugs / interventions tested

1) cupping therapy
2) control test (no intervention)
3) ischemic compression

Conditions studied

Trigger Point Pain, Myofascial — all drugs for Trigger Point Pain, Myofascial →

Sponsor

Józef Piłsudski University of Physical Education

Who can join

Adults 18 to 30, any sex, with Trigger Point Pain, Myofascial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ischemic compression is considered the fastest and most common method for providing relief in trigger point therapy, whereas cupping therapy is not a method often used for this purpose. The muscle that has a great impact on tension-type headaches and neck pain is the trapezius, whose upper fibres are where the most common trigger point in the back is located. The aim of this study was to evaluate and compare the effectiveness of single ischemic compression and single dry cupping therapy on the most common trigger point, on the descending part of the trapezius muscle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Trigger Point Pain, Myofascial

Currently open trials in the same condition.

NCT07138807 — Effect of MET vs Neck Calliet Exercises on Neck Pain and Disability in Nurses · NA · recruiting
NCT06986707 — Strain Counterstrain Technique and Graston Technqiue on Quadratus Lumborum Trigger Points · NA · recruiting
NCT06986317 — Effectiveness of Positional Release Techniques and Graston Technique In Trigger Point · NA · recruiting
NCT06664359 — Safe Zone in Trigger Point Injection · recruiting
NCT06316583 — Clinical Study on Dry Needling for Primary Dysmenorrhea and Its Preliminary Correlation With Acupoints · NA · recruiting

Other Józef Piłsudski University of Physical Education trials

Trials by the same sponsor.

NCT07061041 — Comparison of the Effects of Static Stretching and Full Range of Motion Strength Training on Posterior Band Flexibility · NA · recruiting
NCT06960590 — Determining the Minimal Effective Dose of Static Stretching for Increasing Range of Motion in Adults · NA · active not recruiting
NCT06821477 — Impact of Knee Extension Brace on Quadriceps EMG During ASLR · active not recruiting
NCT06804564 — Cold Vs Warm Water Immersion for DOMS Recovery · NA · recruiting
NCT06896773 — Effect of Training in Normobaric Hypoxia on Cardiac Markers · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05123105 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Józef Piłsudski University of Physical Education
Last refreshed: 17 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05123105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing